http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106074904-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-57 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-074 |
| filingDate | 2016-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106074904-B |
| titleOfInvention | A kind of pharmaceutical composition for the treatment of of acute radiation oral mucositis and preparation method thereof |
| abstract | The invention belongs to field of medicaments, are related to a kind of pharmaceutical composition and preparation method thereof for the treatment of of acute radiation oral mucositis.Technical problem solved by the invention is to provide a kind of pharmaceutical composition for the treatment of of acute radiation oral mucositis.Pharmaceutical composition of the present invention is with radix scrophulariae, endothelium corneum gigeriae galli, silkworm excrement, blackberry lily, and ganoderma lucidum, chlorogenic acid are bulk pharmaceutical chemicals, and pharmaceutically acceptable auxiliary material is added and is prepared.Wherein, ganoderma lucidum has the effects that raising is immune, antitumor, anti-inflammatory, anti-oxidant, to pharmaceutical composition of the present invention for preventing and treating patients with radioactive mucositis of oral cavity with important influence as important constituent.Pharmaceutical composition of the present invention can explicitly improve the malaise symptoms such as the bleeding of side effect oral mucositis, pharyngalgia caused by radiotherapy, influence of the ganoderma lucidum for pharmaceutical composition of the present invention is especially investigated, it specifies the compatibility composition of drug, provides a kind of new selection for side effect oral mucositis caused by clinical treatment radiotherapy. |
| priorityDate | 2016-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.